Sherief Rahit Janmohamed

Sherief Rahit Janmohamed

Auto-generated profile, based on publicly available information

Sherief Rahit Janmohamed

Universitair Ziekenhuis Brussel

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Lancet
Verified
Journal Article
Closed access
JGJennifer B Green
Jennifer B Green
SJSalim Janmohamed
Salim Janmohamed
NJNigel P Jones
Nigel P Jones
ARAnne E Rosenberg
Anne E Rosenberg
KSKristina N Sigmon
Kristina N Sigmon
TMTrisha Mandal
Trisha Mandal

1 June 2014 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
SJSherief R. Janmohamed
Sherief R. Janmohamed
AOArnold P. Oranje
Arnold P. Oranje
ADArjan C. Devillers
Arjan C. Devillers
DRDimitris Rizopoulos
Dimitris Rizopoulos
MPMarinus C.G. van Praag
Marinus C.G. van Praag
FSFlora B. de Waard-Van der Spek
Flora B. de Waard-Van der Spek

16 October 2015 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
EWE. Wedgeworth
E. Wedgeworth
MGM. Glover
M. Glover
Alan IrvineAlan Irvine
Alan Irvine
INIria Neri
Iria Neri
EBE. Baselga
E. Baselga
CFC. Flohr
C. Flohr

21 September 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJonathan Silverberg
Jonathan Silverberg
DLD. Lei
D. Lei
MYM. Yousaf
M. Yousaf
SJS.R. Janmohamed
S.R. Janmohamed
PVP.P. Vakharia
P.P. Vakharia
DHD.Y. Hsu
D.Y. Hsu

10 June 2011 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
SJS. R. Janmohamed
S. R. Janmohamed
FSF. B. de Waard-Van der Spek
F. B. de Waard-Van der Spek
GMG. C. Madern
G. C. Madern
PLP. C. J. de Laat
P. C. J. de Laat
WHW. C. J. Hop
W. C. J. Hop
AOA. P. Oranje
A. P. Oranje

16 December 2011 in Dermatology
Verified
Journal Article
Closed access
AOA.P. Oranje
A.P. Oranje
SJS.R. Janmohamed
S.R. Janmohamed
GMG.C. Madern
G.C. Madern
PLP.C.J. de Laat
P.C.J. de Laat
Background: Haemangioma of infancy (HOI) on the face may be disfiguring and alarming for parents. Usually they are not treated when they are small. Treatment of HOI with propranolol is a breakthrough. Timolol (topical treatment) and propranolol are closely related. Methods: We considered topical treatment with timolol 0.5% ophthalmic solution 3–4 times daily in patients with small HOI. Twenty patients with small mostly superficial HOI were included. Results: A series of 20 patients with HOI treated with timolol 0.5% ophthalmic solution are described. The treatment was effective in all superficial HOIs after 1–4 months. A quick direct inhibitory effect on the growth of the HOI followed by slower regression was observed. The children had to be treated during the whole proliferative phase. Deep HOIs on the nose (2 cases) and lower eyelid (1 case) showed no response. Conclusion: Topical timolol 0.5% ophthalmic solution is effective in HOI. Safety and effectiveness of drugs like topical timolol and topical propranolol require further investigation but they seem very safe when used in small HOIs. We recommend that small superficial HOIs should be treated in an early proliferative phase.